We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
233 hedge funds and large institutions have $2.69B invested in Fate Therapeutics in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 96 increasing their positions, 70 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
37% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 70
31% more call options, than puts
Call options by funds: $4.17M | Put options by funds: $3.19M
8.43% more ownership
Funds ownership: 104.93% → 113.36% (+8.4%)
7% less funds holding
Funds holding: 250 → 233 (-17)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
31% less capital invested
Capital invested by funds: $3.92B → $2.69B (-$1.23B)
34% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 38
Holders
233
Holders Change
-17
Holders Change %
-6.8%
% of All Funds
3.93%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.15%
New
25
Increased
96
Reduced
70
Closed
38
Calls
$4.17M
Puts
$3.19M
Net Calls
+$987K
Net Calls Change
-$2.94M
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$101M |
| 2 |
State Street
Boston,
Massachusetts
|
+$49.6M |
| 3 |
Goldman Sachs
New York
|
+$23.7M |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$20.5M |
| 5 |
AG
Artal Group
Luxembourg
|
+$16.6M |
Top Sellers
| 1 |
CC
Casdin Capital
New York
|
-$35.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$26.7M |
| 3 |
TLP
Tri Locum Partners
New York
|
-$7.38M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.57M |
| 5 |
AWA
Artemis Wealth Advisors
New York
|
-$3.88M |
